1994, 266: R979-R988
The reasons for this vary and may be anecdotal, but operative morbidity may take priority over complete disease resection [27]
(ml and cc are the same) They should have sent you 2 different types of syringes, one 3 ml syringe that you can use to easily draw up the 2 ml of solution and another 1 ml insulin syringe that you will use to give yourself the subcutaneous injection
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
Theres no revenue share, no equity stake, and no long-term contracts to worry about
Furthermore, the peptide allows mechanistic exploration of proteinprotein interactions under controlled conditions